Contact us today for an immediate and confidential review of your case.

First Name

Last Name

Email Address

Phone Number

Cell Phone Number

Street Address

City

State Choose State ALABAMA ALASKA ARIZONA ARKANSAS CALIFORNIA COLORADO CONNECTICUT DELAWARE DISTRICT OF COLUMBIA FLORIDA GEORGIA HAWAII IDAHO ILLINOIS INDIANA IOWA KANSAS KENTUCKY LOUISIANA MAINE MARYLAND MASSACHUSETTS MICHIGAN MINNESOTA MISSISSIPPI MISSOURI MONTANA NEBRASKA NEVADA NEW HAMPSHIRE NEW JERSEY NEW MEXICO NEW YORK NORTH CAROLINA NORTH DAKOTA OHIO OKLAHOMA OREGON PENNSYLVANIA RHODE ISLAND SOUTH CAROLINA SOUTH DAKOTA TENNESSEE TEXAS UTAH VERMONT VIRGINIA WASHINGTON WEST VIRGINIA WISCONSIN WYOMING

Zip Code

Date of birth of injured person (mm/dd/yyyy):

Date you started using Seroquel (mm/dd/yyyy)

Date you stopped using Seroquel (mm/dd/yyyy)

Did you suffer any of the following side effects while using Seroquel?

Diabetes
Hyperglycemia
Pancreatitis
Other blood sugar disorder
Other side effect(s)

Please describe treatment for side effects

Other information

By submitting this form I agree to the following disclaimer.

Seroquel Linked to Diabetes and Hyperglycemia

This is a Sub Title

In aliquet euismod ante. Suspendisse tempor, ligula vitae bibendum rhoncus, risus diam scelerisque est, vel fermentum risus est a sapien. Nullam neque tellus, posuere in, volutpat id, semper vel, lacus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos hymenaeos. Fusce sed tortor vel tellus dictum nonummy. Nunc tincidunt leo nec purus. This is a link. Aliquam lacinia sagittis nisl. Curabitur blandit, elit eget laoreet ornare, purus lectus vehicula velit, ut hendrerit felis nulla nec nunc. Sed ultrices, justo sed ornare lobortis, lorem pede ultricies lacus, eget commodo sapien tellus ut est. Nunc lectus sapien, feugiat nec, imperdiet sit amet, feugiat at, enim.

This is another title for a list

In aliquet euismod ante. Suspendisse tempor, ligula vitae bibendum rhoncus, risus diam scelerisque est, vel fermentum risus est a sapien. Nullam neque tellus, posuere in, volutpat id, semper vel, lacus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos hymenaeos. Fusce sed tortor vel tellus dictum nonummy. Nunc tincidunt leo nec purus. This is a link. Aliquam lacinia sagittis nisl. Curabitur blandit, elit eget laoreet ornare, purus lectus vehicula velit, ut hendrerit felis nulla nec nunc. Sed ultrices, justo sed ornare lobortis, lorem pede ultricies lacus, eget commodo sapien tellus ut est. Nunc lectus sapien, feugiat nec, imperdiet sit amet, feugiat at, enim.

FDA MEDWATCH

Safety Alert: Seroquel® (quetiapine fumarate)

WARNINGS:
Hyperglycemia and Diabetes Mellitus

Hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical antipsychotics, including Seroquel. Assessment of the relationship between atypical antipsychotic use and glucose abnormalities is complicated by the possibility of an increased background risk of diabetes mellitus in patients with schizophrenia and the increasing incidence of diabetes mellitus in the general population. Given these confounders, the relationship between atypical antipsychotic use and hyperglycemia-related adverse events is not completely understood. However, epidemiological studies suggest an increased risk of treatment-emergent hyperglycemia-related adverse events in patients treated with the atypical antipsychotics. Precise risk estimates for hyperglycemia-related adverse events in patients treated with atypical antipsychotics are not available. Patients with an established diagnosis of diabetes mellitus who are started on atypical antipsychotics should be monitored regularly for worsening of glucose control.

Patients with risk factors for diabetes mellitus (eg, obesity, family history of diabetes) who are starting treatment with atypical antipsychotics should undergo fasting blood glucose testing at the beginning of treatment. Any patient treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. Patients who develop symptoms of hyperglycemia during treatment with atypical antipsychotics should undergo fasting blood glucose testing. In some cases, hyperglycemia has resolved when the atypical antipsychotic was discontinued; however, some patients required continuation of anti-diabetic treatment despite discontinuation of the suspect drug.

AstraZeneca remains committed to providing you with the most current product information available for the management of your patients. You may immediately review the Warnings statement about hyperglycemia and diabetes mellitus in the SEROQUEL Prescribing Information by visiting the web site www.Seroquel.com. Updated package inserts containing the additional hyperglycemia and diabetes mellitus information will accompany the medication in the near future and you should, of course, refer to the insert for full Prescribing Information.